Experimental studies revealed that SGK3 was an oncogenic gene [70,71]; however, TCGA analysis of several cancer data indicated SGK3 was downregulated compared with controls (including lung cancer, which was also confirmed in our prognosis and HPA analyses) (Figure S8). This evidence concerns the gene SGK3 and lung carcinoma.